Pelotonia Institute for Immuno-Oncology

the pelotonia institute for immuno-oncology

the next frontier in prevention & treatment

The Pelotonia Institute for Immuno-Oncology is a comprehensive bench-to-bedside research initiative focused on harnessing the body’s immune system to fight cancer at all levels — from prevention to treatment and survivorship.

The Pelotonia Institute for Immuno-Oncology was established in 2019 through a $102 million pledge from Pelotonia to pioneer a landmark initiative focused on harnessing the body’s immune system to fight cancer at all levels — the next frontier of cancer prevention and treatment.

About the pelotonia institute for immuno-oncology

the piio

The Pelotonia Institute for Immuno-Oncology is a comprehensive bench-to-clinical-trial research initiative that will accelerate advanced cellular therapies that harness the immune system to fight cancer.

vision & Ambition

Move toward a cancer cure by advancing immuno-oncology, and being a leader in driving immuno-oncology breakthroughs.

Five Strategic Goals

Top talent, groundbreaking research, and global collaborations to push scientific boundaries. Together, we’re harnessing the power of the immune system to create a world without cancer.

TRANSFORMATIVE RESEARCH

Our cutting-edge laboratories are incubators for revolutionary ideas. Here, brilliant minds collaborate to unlock the secrets of the immune system, developing novel therapies that could redefine cancer treatment. From innovative cell therapies to groundbreaking immunogenomics, we’re pushing the boundaries.

EDUCATIONAL EXCELLENCE

We’re not just conducting research; we’re shaping the future of immuno-oncology. Our comprehensive training programs and mentorship initiatives nurture the next generation of IO researchers and clinicians. By investing in education, we’re ensuring a continuous pipeline of talent to drive innovation for years to come.

COMMUNITY IMPACT

Our work extends beyond the lab, directly touching lives in our community and beyond. Through patient education programs, community outreach, and partnerships with advocacy groups, we’re raising awareness about immuno-oncology and its potential. Our efforts empower patients, inspire hope, and build support.

Since founding in 2019

124 PIIO members awarded $43 million in annual grant funding ($25M from NCI)

254 immunotherapy clinical trials launched

1,450+ peer-reviewed articles published

Current (2024)

12 new PIIO members, including 4 new recruits

32 new grants, $5 million in annual grant funding ($3.6M from NCI)

206 peer-reviewed articles

research story

Ohio State Recruits Renowned Researcher in Immunology

In connection to funds raised by the Pelotonia community, Glen Barber, PhD, FRS, a globally distinguished immunologist, was recruited to join the PIIO as director of the Center for Innate Immunity and Inflammation. His groundbreaking work focuses on the body’s innate immune system, which is considered to be the first line of defense against diseases.

Read the Story